Definitive Healthcare (NASDAQ:DH) Releases Quarterly Earnings Results, Beats Estimates By $0.02 EPS

Definitive Healthcare (NASDAQ:DH) issued its quarterly earnings data on Thursday. The company reported $0.06 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.04 by $0.02, FiscalAI reports. Definitive Healthcare had a positive return on equity of 4.07% and a negative net margin of 69.18%. The business had revenue of $54.65 million during the quarter, compared to analysts’ expectations of $54.58 million.

Definitive Healthcare Price Performance

Shares of DH stock traded up $0.02 during mid-day trading on Friday, hitting $1.15. 324,402 shares of the stock were exchanged, compared to its average volume of 394,086. The firm has a fifty day moving average of $1.02 and a 200 day moving average of $1.06. The company has a quick ratio of 1.86, a current ratio of 1.86 and a debt-to-equity ratio of 0.81. Definitive Healthcare has a 52-week low of $0.61 and a 52-week high of $3.00. The company has a market cap of $122.76 million, a PE ratio of -0.77, a price-to-earnings-growth ratio of 14.19 and a beta of 1.40.

Analyst Upgrades and Downgrades

Several research analysts recently weighed in on DH shares. Wall Street Zen upgraded Definitive Healthcare from a “hold” rating to a “buy” rating in a research report on Sunday, September 13th. Weiss Ratings upgraded Definitive Healthcare from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Wednesday. Deutsche Bank Aktiengesellschaft reaffirmed a “hold” rating and set a $1.00 price objective on shares of Definitive Healthcare in a research note on Wednesday, August 12th. BTIG Research reaffirmed a “neutral” rating on shares of Definitive Healthcare in a research note on Friday, September 4th. Finally, Morgan Stanley cut their target price on shares of Definitive Healthcare from $2.50 to $1.50 and set an “equal weight” rating for the company in a report on Tuesday, August 11th. Six investment analysts have rated the stock with a Hold rating and three have given a Sell rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Reduce” and a consensus price target of $1.47.

About Definitive Healthcare

Definitive Healthcare Corp. (NASDAQ: DH) provides data, analytics and commercial intelligence solutions for the healthcare industry. Its platform is designed to help organizations understand healthcare markets, identify business opportunities and make data-driven decisions.

The company serves pharmaceutical and biotechnology companies, medical device manufacturers, healthcare providers, hospitals and health systems, and other healthcare services organizations. Its offerings include information on healthcare providers and organizations, market intelligence, sales and marketing analytics, clinical trial insights, and tools that support commercial planning, market access and customer engagement.

Definitive Healthcare was founded in 2011 and became a publicly traded company in 2021.